[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"overactive-detrusor\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:overactive-detrusor":45},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":16,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":28,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":5},"100508026",false,"NCT05895045","Yoga for Treatment of Overactive Bladder in Pediatric Patients","Inclusion Criteria:\n\n* 8-18 years of age\n* History of non-neurogenic overactive bladder or detrusor overactivity and\u002For urinary incontinence (ICD 10 codes respectively - N32.81, N39.498)\n* Obtained legally effective informed consent and Health Insurance Portability and Accountability Act (HIPPA) authorization from the participant or the participant's parent\u002Flegal guardian\n* Minor participant is willing and able to provide assent (as applicable)\n* Vancouver Dysfunctional Elimination Syndrome\\[15\\] score of ≥11 and a positive modified bother score within 30 days of consent\n\nExclusion Criteria:\n\n* Known or apparent untreated anatomical abnormality of lower urinary tract (i.e. untreated ureterocele)\n* Known neurogenic bladder (e.g., spina bifida, history of spinal cord injury, tethered cord)\n* Nerve damage that may impact pelvic floor function\n* History of chemodenervation of the bladder (e.g., via intravesical instillation or intradetrusor injection of botulinum toxin)\n* Active, untreated UTI at the time of enrollment (UTI undergoing active treatment is allowable)\n* Current or previous pregnancy at screening or planned pregnancy during the duration of the study, for females of childbearing potential\n* Any condition that, in the judgment of the investigator or treating clinician, precludes participation because it could affect participant safety","ALL","8 Years","18 Years",{"count":18,"type":19},40,"ESTIMATED","INTERVENTIONAL",[22],"NA","The goal of this pilot study is to assess the impact of yoga as a treatment modality in pediatric patients age 8-18 diagnosed with idiopathic overactive bladder as measured by validated questionnaires and urinary biomarkers. The main question it aims to answer is: Does yoga help improve overactive bladder symptoms in this patient population? Participants will take part in a weekly yoga session for a total of 6 weeks with validated questionnaires and urinary samples for biomarkers to be completed at the beginning, middle and end of the study. This study will follow a cross-over study design and patients will receive standard of care while not in the active treatment arm.",[25,26,27],"Overactive Bladder","Overactive Bladder Syndrome","Overactive Detrusor",[29,30,31,32],"bladder","overactive","detrusor","pediatric","RECRUITING","2026-01-29",{"date":36,"type":37},"2026-01-30","ACTUAL",{"date":39,"type":37},"2026-01-01",{"date":41,"type":19},"2026-12-31",{"name":43,"class":44},"Duke University","OTHER",""]